Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imatinib Resistant”

Showing 20 of 0 results

Not applicableApproved For MarketingNCT00905593
What this trial is testing

Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00384228
What this trial is testing

A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT00101647
What this trial is testing

Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Bristol-Myers Squibb 197
Not applicableNo Longer AvailableNCT01549548
What this trial is testing

Compassionate Use Ponatinib

Who this might be right for
Philadelphia Chromosome Positive (Ph+) LeukemiasChronic Myeloid Leukemia
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00777036
What this trial is testing

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Who this might be right for
Leukemia
Bristol-Myers Squibb 133
Early research (Phase 1)Study completedNCT01743300
What this trial is testing

The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients

Who this might be right for
Healthy
Leiden University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00633295
What this trial is testing

Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor

Who this might be right for
Gastrointestinal Stromal Tumors (GIST)
Novartis Pharmaceuticals 9
Testing effectiveness (Phase 2)Study completedNCT01506336
What this trial is testing

Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

Who this might be right for
Gastro Intestinal Stromal Tumor
AB Science 44
Testing effectiveness (Phase 2)Study completedNCT00455559
What this trial is testing

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

Who this might be right for
Gastrointestinal Stromal Tumors
AEterna Zentaris 40
Testing effectiveness (Phase 2)Study completedNCT00811070
What this trial is testing

Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias

Who this might be right for
Chronic Myelogenous Leukemia
Pfizer 63
Large-scale testing (Phase 3)Study completedNCT01392469
What this trial is testing

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 21
Post-approval studies (Phase 4)Study completedNCT01206088
What this trial is testing

Tasigna in Glivec-resistant or Intolerant Patients in CML

Who this might be right for
CMLNilotinibImatinib Resistant+1 more
Novartis Pharmaceuticals 93
Early research (Phase 1)Study completedNCT01077544
What this trial is testing

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 15
Testing effectiveness (Phase 2)UnknownNCT03171389
What this trial is testing

POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST

Who this might be right for
GIST, MalignantKIT Exon 13 MutationKIT Gene Mutation
Sebastian Bauer 81
Testing effectiveness (Phase 2)Study completedNCT00385203
What this trial is testing

The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
AstraZeneca 35
Testing effectiveness (Phase 2)UnknownNCT03697668
What this trial is testing

Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites

Who this might be right for
Plasmodium Falciparum Malaria (Drug Resistant)
Nurex S.r.l. 50
Testing effectiveness (Phase 2)Study completedNCT00006053
What this trial is testing

STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

Who this might be right for
Leukemia
Novartis
Not applicableUnknownNCT02034656
What this trial is testing

Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)

Who this might be right for
Chronic Myeloid Leukemia or Ph Positive ALL
Seoul St. Mary's Hospital 125
Testing effectiveness (Phase 2)Study completedNCT00101660
What this trial is testing

Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib

Who this might be right for
Chronic Myeloid LeukemiaPhiladelphia-Positive Myeloid Leukemia
Bristol-Myers Squibb 387
Testing effectiveness (Phase 2)Study completedNCT00337454
What this trial is testing

Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan

Who this might be right for
Chronic Myelogenous Leukemia
Bristol-Myers Squibb 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation